Correlation Between Pfizer and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Pfizer and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Pfizer and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Cardio Diagnostics.
Diversification Opportunities for Pfizer and Cardio Diagnostics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and Cardio is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Pfizer i.e., Pfizer and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Pfizer and Cardio Diagnostics
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.16 times more return on investment than Cardio Diagnostics. However, Pfizer Inc is 6.32 times less risky than Cardio Diagnostics. It trades about 0.21 of its potential returns per unit of risk. Cardio Diagnostics Holdings is currently generating about -0.1 per unit of risk. If you would invest 2,119 in Pfizer Inc on April 10, 2025 and sell it today you would earn a total of 443.00 from holding Pfizer Inc or generate 20.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Cardio Diagnostics Holdings
Performance |
| Timeline |
| Pfizer Inc |
| Cardio Diagnostics |
Pfizer and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Cardio Diagnostics
The main advantage of trading using opposite Pfizer and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.| Pfizer vs. Agilent Technologies | Pfizer vs. Equillium | Pfizer vs. KING PHARMACEUTICALS INC | Pfizer vs. DiaMedica Therapeutics |
| Cardio Diagnostics vs. Precision Drilling | Cardio Diagnostics vs. Where Food Comes | Cardio Diagnostics vs. Integrated Drilling Equipment | Cardio Diagnostics vs. SD Standard Drilling |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |